Annual EBITDA
-$11.32M$7.94M-235.19%
Summary
- Current Value
- As of today, RGC annual EBITDA is -$11.32M, down -235.19% on
- Historical Performance
- RGC annual EBITDA is down -105.67% over the past 3 years, down -735.48% over the past 5 years
- All-Time High Comparison
- RGC annual EBITDA is currently -2795.12% below its historical high of -$391.00K set on
- 3-Year Low Comparison
- RGC annual EBITDA is at its 3-year low
- Sector Comparison
- RGC annual EBITDA is higher than 54.42% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$11.32M | -235.2% | -105.7% | -735.5% | -2795.1% | |
| Quarterly EBITDA | - | – | – | – | – | |
| TTM EBITDA | - | – | – | – | – | |
| Price | $7.63 | -60.7% | +1547.2% | +1417.2% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Annual EPS | -$0.02 | -229.2% | +94.8% | +77.8% | +23.3% | |
| -$11.72M | -211.0% | -86.9% | -748.7% | -2898.6% | ||
| Annual Net Income | -$11.70M | -226.5% | -93.0% | -768.9% | -2892.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$3.38M | -235.2% | |
| 5Y | -$1.35M | N/A | -735.5% |
| All | -$391.00K | -2795.1% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$11.32M | at low | |
| 5Y | -$11.32M | at low | |
| All | -$11.32M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$11.32M | -235.2% | |
| -$3.38M | +15.4% | |
| -$3.99M | +27.5% | |
| -$5.50M | +21.5% |
| Year | Value | Change |
|---|---|---|
| -$7.01M | -417.6% | |
| -$1.35M | -68.8% | |
| -$802.80K | -105.3% | |
| -$391.00K | - |
FAQ
- What is the current annual EBITDA of RGC?
- As of today, RGC annual EBITDA is -$11.32M
- What is 1-year change in RGC annual EBITDA?
- RGC annual EBITDA is down -235.19% year-over-year
- What is 3-year change in RGC annual EBITDA?
- RGC annual EBITDA is down -105.67% over the past 3 years
- How far is RGC annual EBITDA from its all-time high?
- RGC annual EBITDA is currently -2795.12% below its historical high of -$391.00K set on June 30, 2019
- How does RGC annual EBITDA rank versus sector peers?
- RGC annual EBITDA is higher than 54.42% of companies in Healthcare sector
- When is RGC next annual earnings release?
- As of today, the next annual earnings release for RGC has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- RGC Official Website www.regencellbioscience.com
- RGC Profile on Yahoo Finance finance.yahoo.com/quote/RGC
- RGC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgc